Nuwellis announces first successful outpatient application of Aquadex Smartflow

Nuwellis (NUWE) announced that the first patients have been successfully treated with Aquadex ultrafiltration therapy in a hospital-based outpatient setting. This milestone reflects a major advancement in the company’s mission to improve access to fluid management and support better care across the continuum. “For patients struggling with fluid overload, access to consistent, effective therapy can make a life-changing difference,” said John Erb, CEO of Nuwellis. “This milestone represents more than just a shift in setting-it reflects our vision for expanding how care is delivered and making fluid management more flexible, scalable, and patient-centered.”